Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/6443
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Şengül, C. | - |
dc.contributor.author | Erdal, M.E. | - |
dc.contributor.author | Aydin, N. | - |
dc.contributor.author | Balci Şengül, C. | - |
dc.contributor.author | Barlas, Ö. | - |
dc.contributor.author | Aynacioglu, Ş. | - |
dc.contributor.author | Herken, H. | - |
dc.date.accessioned | 2019-08-16T12:07:24Z | - |
dc.date.available | 2019-08-16T12:07:24Z | - |
dc.date.issued | 2010 | - |
dc.identifier.issn | 1302-6631 | - |
dc.identifier.uri | https://hdl.handle.net/11499/6443 | - |
dc.description.abstract | Objective: Antipsychotic induced weight gain is a major problem for second generation antipsychotics which may lead to diabetes and metabolic syndrome. Recent studies were mentioning that genetic factors might be relevant in antipsychotic induced weight gain. Aim of this study is evaluation of the association between IRS-1 Glyp972Arg polymorphism and olanzapine induced weight gain. Methods: Total of 95 patients whom were diagnosed as schizophrenia by DSM-IV criteria were included to study. Body weight, body mass index and blood glucose levels of all patients were checked at the beginning and six weeks after olanzapine treatment. Blood for DNA analysis were obtained from patients and analyzed as mentioned in literature. Data were evaluated with descriptive methods and Mann Whitney U test was used for comparison of two groups. Results: Eighty and four of patients had Glycine/Glycine and 11 patients had Glycine/Arginine genotype of IRS-1 Gly972Arg polymorphism. Despite the patients with Glycine/Glycine polymorphism gained more weight than patients with Glycine/Arginine polymorphism, the difference between Glycine/Glycine and Glycine/Arginine groups for weight change and body mass index change wasn't statistically significant. Conclusion: Our results showed no statistical relationship between the IRS-1 Gly972Arg polymorphism and olanzapine induced weight gain. However exploration of the other IRS genotypes and the antipsychotic-induced body weight change may help in the understanding of the mechanisms of antipsychotic-induced body weight gain. | en_US |
dc.language.iso | tr | en_US |
dc.relation.ispartof | Anadolu Psikiyatri Dergisi | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | IRS | en_US |
dc.subject | Olanzapine | en_US |
dc.subject | Pharmacogenetics | en_US |
dc.subject | Weight gain | en_US |
dc.subject | arginine | en_US |
dc.subject | glucose | en_US |
dc.subject | glycine | en_US |
dc.subject | insulin receptor substrate 1 | en_US |
dc.subject | olanzapine | en_US |
dc.subject | article | en_US |
dc.subject | blood sampling | en_US |
dc.subject | body mass | en_US |
dc.subject | body weight | en_US |
dc.subject | controlled study | en_US |
dc.subject | DNA determination | en_US |
dc.subject | genetic association | en_US |
dc.subject | genotype | en_US |
dc.subject | glucose blood level | en_US |
dc.subject | human | en_US |
dc.subject | major clinical study | en_US |
dc.subject | mental patient | en_US |
dc.subject | molecular mechanics | en_US |
dc.subject | schizophrenia | en_US |
dc.subject | side effect | en_US |
dc.subject | single nucleotide polymorphism | en_US |
dc.subject | treatment duration | en_US |
dc.subject | weight change | en_US |
dc.subject | weight gain | en_US |
dc.title | The relation between IRS-1 Gly972Arg (insulin receptor substrate) gene polymorphism and olanzapine induced weight gain | en_US |
dc.type | Article | en_US |
dc.identifier.volume | 11 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.startpage | 18 | - |
dc.identifier.startpage | 18 | en_US |
dc.identifier.endpage | 22 | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.identifier.scopus | 2-s2.0-77749341437 | en_US |
dc.identifier.wos | WOS:000275055700003 | en_US |
dc.identifier.scopusquality | Q4 | - |
dc.owner | Pamukkale University | - |
item.openairetype | Article | - |
item.languageiso639-1 | tr | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
item.fulltext | With Fulltext | - |
item.grantfulltext | open | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
Appears in Collections: | Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu TR Dizin İndeksli Yayınlar Koleksiyonu / TR Dizin Indexed Publications Collection WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Files in This Item:
File | Size | Format | |
---|---|---|---|
f0a05c3c-7682-463f-be6b-b443172cfbbb.pdf | 242.12 kB | Adobe PDF | View/Open |
CORE Recommender
SCOPUSTM
Citations
2
checked on Oct 13, 2024
WEB OF SCIENCETM
Citations
2
checked on Oct 31, 2024
Page view(s)
54
checked on Aug 24, 2024
Download(s)
138
checked on Aug 24, 2024
Google ScholarTM
Check
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.